26 February 2019 Oyster Point Raises $93 Million to Support the Clinical Development of Novel Treatment for Dry Eye Disease read more
13 December 2017 Pionyr Immunotherapeutics Completes $62 Million Series B Financing to Advance Antibody-based Therapeutics Targeting the Tumor Microenvironment read more